While all of these studies pointed towards possible integrin-dependent functions for the CD9/CD81 complex in breast carcinoma cells, the specific integrins involved in each study were not defined, and, in particular, the specific contribution of α3β1 integrin was not assessed. The gene discussed is CD9; the disease is breast carcinoma.